0001209191-20-008055.txt : 20200210
0001209191-20-008055.hdr.sgml : 20200210
20200210180028
ACCESSION NUMBER: 0001209191-20-008055
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200206
FILED AS OF DATE: 20200210
DATE AS OF CHANGE: 20200210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RUBINO RICHARD J
CENTRAL INDEX KEY: 0001252014
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36152
FILM NUMBER: 20593230
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AERIE PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001337553
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 203109565
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4301 EMPEROR BOULEVARD
STREET 2: SUITE 400
CITY: DURHAM
STATE: NC
ZIP: 27703
BUSINESS PHONE: (919) 237-5300
MAIL ADDRESS:
STREET 1: 4301 EMPEROR BOULEVARD
STREET 2: SUITE 400
CITY: DURHAM
STATE: NC
ZIP: 27703
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-02-06
0
0001337553
AERIE PHARMACEUTICALS INC
AERI
0001252014
RUBINO RICHARD J
C/O AERIE PHARMACEUTICALS, INC.
4301 EMPEROR BLVD., SUITE 400
DURHAM
NC
27703
0
1
0
0
Chief Financial Officer
Common Stock
2020-02-06
4
A
0
11750
0.00
A
351196
D
Stock Option (right to buy)
21.18
2020-02-06
4
A
0
52000
0.00
A
2030-02-06
Common Stock
52000
52000
D
These shares of Common Stock are scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in equal installments on each of the first four anniversaries of February 6, 2020.
This option is scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in equal installments on each of the first 48 monthly anniversaries of February 6, 2020.
/s/ John LaRocca, Attorney-in-Fact for Richard J. Rubino
2020-02-10